Magdolna Tardy

2.2k total citations · 1 hit paper
13 papers, 1.4k citations indexed

About

Magdolna Tardy is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Magdolna Tardy has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 5 papers in Pharmacology and 3 papers in Clinical Psychology. Recurrent topics in Magdolna Tardy's work include Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Treatment of Major Depression (5 papers). Magdolna Tardy is often cited by papers focused on Schizophrenia research and treatment (13 papers), Bipolar Disorder and Treatment (6 papers) and Treatment of Major Depression (5 papers). Magdolna Tardy collaborates with scholars based in Germany, United States and China. Magdolna Tardy's co-authors include Stefan Leucht, Werner Kissling, John M. Davis, Katja Komossa, Stephan Heres, Georgia Salanti, Markus Dold, Maximilian Huhn, Myrto Samara and Chunbo Li and has published in prestigious journals such as The Lancet, Cochrane Database of Systematic Reviews and JAMA Psychiatry.

In The Last Decade

Magdolna Tardy

13 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

2012 594 citations Stefan Leucht, Magdolna Tardy et al. The Lancet profile →

Peers

Magdolna Tardy

PMH

CP

PHILO

PHARM

SP

Claudia Leucht Germany

Gabriele Pitschel‐Walz Germany

J. Peuskens Belgium

Spyridon Siafis Germany

J.M. Olivares Spain

Luchezar Hranov Israel

Philipp Rothe Germany

Ananda K. Pandurangi United States

Anna Eramo United States

S. Leucht Germany

Claudia Leucht Germany

Magdolna Tardy

1.2k ×1.2

PMH

410 ×1.1

CP

333 ×1.2

PHILO

286 ×1.4

PHARM

136 ×0.8

SP

Citations per year, relative to Magdolna Tardy Magdolna Tardy (= 1×) peers Claudia Leucht

Countries citing papers authored by Magdolna Tardy

Since Specialization

Citations

This map shows the geographic impact of Magdolna Tardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdolna Tardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdolna Tardy more than expected).

Fields of papers citing papers by Magdolna Tardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdolna Tardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdolna Tardy. The network helps show where Magdolna Tardy may publish in the future.

Co-authorship network of co-authors of Magdolna Tardy

This figure shows the co-authorship network connecting the top 25 collaborators of Magdolna Tardy. A scholar is included among the top collaborators of Magdolna Tardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdolna Tardy. Magdolna Tardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Ceraso, Anna, Jingxia Lin, Johannes Schneider‐Thoma, et al.. (2020). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2020(8). 114 indexed citations

2.

Dold, Markus, Magdolna Tardy, Myrto Samara, et al.. (2016). Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials. The World Journal of Biological Psychiatry. 17(3). 210–220. 1 indexed citations

3.

Dold, Markus, Myrto Samara, Chunbo Li, Magdolna Tardy, & Stefan Leucht. (2015). Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Cochrane Database of Systematic Reviews. 2015(1). CD009831–CD009831. 68 indexed citations

4.

Tardy, Magdolna, Markus Dold, Rolf R. Engel, & Stefan Leucht. (2014). Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2014(7). CD009396–CD009396. 16 indexed citations

5.

Tardy, Magdolna, Maximilian Huhn, Rolf R. Engel, & Stefan Leucht. (2014). Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2014(8). CD009230–CD009230. 19 indexed citations

6.

Huhn, Maximilian, Magdolna Tardy, Loukia M. Spineli, et al.. (2014). Efficacy of Pharmacotherapy and Psychotherapy for Adult Psychiatric Disorders. JAMA Psychiatry. 71(6). 706–706. 199 indexed citations

7.

Tardy, Magdolna, Maximilian Huhn, Werner Kissling, Rolf R. Engel, & Stefan Leucht. (2014). Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2014(7). CD009268–CD009268. 57 indexed citations

8.

Tardy, Magdolna, Maximilian Huhn, Rolf R. Engel, & Stefan Leucht. (2014). Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2014(10). 15 indexed citations

9.

Tardy, Magdolna, Markus Dold, Rolf R. Engel, & Stefan Leucht. (2014). Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 2014(9). CD009227–CD009227. 7 indexed citations

10.

Tardy, Magdolna, Maximilian Huhn, Werner Kissling, Rolf R. Engel, & Stefan Leucht. (2014). Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia. Advances in Psychiatric Treatment. 20(5). 296–296. 9 indexed citations

11.

Dold, Markus, et al.. (2012). Benzodiazepines for schizophrenia. Cochrane Database of Systematic Reviews. 2012(11). CD006391–CD006391. 95 indexed citations

12.

Leucht, Stefan, Magdolna Tardy, Katja Komossa, et al.. (2012). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. The Lancet. 379(9831). 2063–2071. 594 indexed citations breakdown →

13.

Leucht, Stefan, Magdolna Tardy, Katja Komossa, et al.. (2012). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews. 8(5). CD008016–CD008016. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact